Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Optimind Pharma Corp. (OMND.CN)

Optimind Pharma Corp. (OMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Optimind Pharma Corp. 40 King Street W Suite 2400, Scotia Plaza Toronto ON M5H 3Y2 CAN

https://www.optimindpharma.com P: 647-891-9379

Sector:

N/A

Description:

Optimind Pharma Corp, through its clinic, specializes in prescribing medical cannabis and other alternative treatments for various medical ailments. It offers psychedelic-like therapies at its clinic, helping people suffering from PTSD, anxiety, depression, and other mental illnesses and disabilities by providing ketamine-assisted treatment and other psychedelic-enhanced psychotherapy modalities. The company is also partnered with developers of psilocybin-associated treatments and products to further expand its treatment and program offerings.

Key Statistics

Overview:

Market Capitalization, $K 516
Shares Outstanding, K 103,148
Annual Sales, $ 118 K
Annual Net Income, $ -216 K
Last Quarter Sales, $ 27 K
Last Quarter Net Income, $ -11 K
60-Month Beta 0.29

Growth:

1-Year Return 0.00%
3-Year Return 0.00%
5-Year Return 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 10/30/25
Next Earnings Date N/A
Earnings Per Share ttm 0.00
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -93.33%
Dividend Payout Ratio 0.00%

OMND.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -21.96%
Profit Margin % -182.32%
Debt/Equity N/A
Price/Sales 4.33
Price/Book N/A
Book Value/Share 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar